Remove Behavioural Health Remove Clinical Trials Remove Marketing
article thumbnail

Sanofi forges $30m alliance with digital health firm DarioHealth

pharmaphorum

DarioHealth has beefed up its sales and marketing channels as well as its range of digital health products thanks to a $30 million strategic alliance with drugmaker Sanofi. Erez Raphael.

article thumbnail

What we’re expecting in 2021, and beyond…

pharmaphorum

There is an opportunity to address this at scale with digital tools and techniques, and expand support into just about any therapeutic area through the holistic integration of mental and behavioural health solutions that improve patient care. Clinical trials get more and more digitalised.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Partnering to advance digital therapeutics offerings

pharmaphorum

Gani started BehaVR in 2016 to create DTx for mental and behavioural health. He says after a meeting between him and a leader at Sumitomo in 2018 or 2019, it became apparent both companies believed in the power of VR in mental health care. They also understand how to do clinical trial design,” Gani states.

article thumbnail

Ohio is third state to fund Pear’s digital therapeutics to tackle addiction

pharmaphorum

The company has been pushing for more reimbursement of its three marketed DTx products in the US following a first FDA approval in 2017. Pear noted that the grant comes at a time when many communities are seeing increased demand for behavioural health and recovery services amid the ongoing coronavirus pandemic.

article thumbnail

Applied Virtual Reality in Healthcare: A comprehensive book on medical XR

pharmaphorum

Immersive technology can also help improve assessments of the effectiveness of treatment, particularly regarding behavioural health where a patient’s results are often subjective. For example, mental health disorders and cognitive decline are rising.

article thumbnail

FDA green lights Oxehealth vital signs monitoring software

pharmaphorum

In a clinical trial, the software was found to be accurate to within three beats per minute for pulse rate compared to contact pulse oximeters, and two breaths per minute for estimated breathing rate. The approval means the Oxford University spin-out can place Oxevision on the market in all US states.

Nurses 59
article thumbnail

Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022

pharmaphorum

Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. Clinical trials technology company Saama has hired Dr Clinton White as its new chief delivery officer. We’ve rounded up some highlights below. Digital therapeutics hires.